HANDS: Electronic Hand Hygiene Monitoring and ICU Infection Rates

Sponsor
Royal Brompton & Harefield NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT02511925
Collaborator
(none)
1,065
1
8
134

Study Details

Study Description

Brief Summary

If patients acquire a new infection whilst in hospital this can cause significant morbidity, prolonged hospitalisation and even death. Indeed, there is much public concern about infections such as MRSA. Patients who require intensive care are probably at the greatest risk.

Appropriate hand hygiene by healthcare workers can reduce infection rates and is a key goal of many patient safety initiatives. Worldwide, hand hygiene compliance has been estimated at only 38.7% despite the intervention being simple and cheap. Reasons for poor compliance include lack of time, skin irritation, lack of facilities, intensity of workload and forgetfulness. Furthermore, since cross infection may not be apparent for some days, staff may not associate their (lack of) actions with having caused harm.

Measuring compliance levels enables staff to understand whether they could improve. Direct observation of staff is labour intensive and is not continuous or universal. We will monitor hand hygiene compliance with a newly developed electronic system (MedSense, General Sensing Inc.). We will use the data to provide feedback to the staff in several ways. We hypothesise that comprehensive personalised feedback will reduce healthcare associated infections. We will undertake the study in three intensive care units.

Condition or Disease Intervention/Treatment Phase
  • Other: Weekly poster of unit performance
  • Other: Daily email of personal feedback
  • Other: Active reminder from badge

Detailed Description

All patients admitted to three intensive care units will be monitored for healthcare associated infections. In parallel the units will be cluster randomised to implement the electronic compliance monitoring in three different ways:

  • Unit level feed back every week of current compliance for each of three staff groupings (doctors, nurses, allied health professionals)

  • Personalised feedback in the form of an email at the end of a shift stating an individuals performance relative to the average for their professional grouping.

  • Real time feedback in the form of a badge worn by the healthcare worker that vibrates when the system thinks they have missed or are about to miss an opportunity for hand hygiene.

All healthcare workers will receive the level of feedback defined in the randomisation for the duration of the three intervention periods. The units will cross-over with an interventing two week wash out period.

All personal feedback will be confidential and private to the individual.

Study Design

Study Type:
Observational
Actual Enrollment :
1065 participants
Observational Model:
Case-Crossover
Time Perspective:
Prospective
Official Title:
A Pragmatic Crossover Cluster Randomised Study of Electronic Compliance Monitoring of Staff Hand Sanitisation in Critical Care (HANDS Study)
Study Start Date :
Nov 1, 2013
Actual Primary Completion Date :
Jul 1, 2014
Actual Study Completion Date :
Jul 1, 2014

Arms and Interventions

Arm Intervention/Treatment
ICU Cluster 1

Adult Intensive Care Unit - Royal Brompton Hospital

Other: Weekly poster of unit performance
Weekly feedback is provided to the ICU about current levels of hand hygiene compliance amongst doctors, nurses, and allied healthcare professionals

Other: Daily email of personal feedback
Healthcare workers receive private and personal feedback via email regarding their individual performance benchmarked against the average performance for their professional grouping.

ICU Cluster 2

Paediatric ICU - Royal Brompton Hospital

Other: Weekly poster of unit performance
Weekly feedback is provided to the ICU about current levels of hand hygiene compliance amongst doctors, nurses, and allied healthcare professionals

Other: Daily email of personal feedback
Healthcare workers receive private and personal feedback via email regarding their individual performance benchmarked against the average performance for their professional grouping.

Other: Active reminder from badge
The badge the healthcare worker is wearing vibrates if opportunities to perform hand hygiene are missed

ICU Cluster 3

Adult Intensive Care Unit - Harefield Hospital

Other: Weekly poster of unit performance
Weekly feedback is provided to the ICU about current levels of hand hygiene compliance amongst doctors, nurses, and allied healthcare professionals

Other: Daily email of personal feedback
Healthcare workers receive private and personal feedback via email regarding their individual performance benchmarked against the average performance for their professional grouping.

Other: Active reminder from badge
The badge the healthcare worker is wearing vibrates if opportunities to perform hand hygiene are missed

Outcome Measures

Primary Outcome Measures

  1. Composite health care infection rate [Until the end of the second calendar day following ICU discharge]

    One of the following three: Bacteriological proven infection at a normally sterile site. The sterile sites vein considered are a prior defined as blood, broncho-alveolar lavage, urine sampled from a catheter, chest drain fluid, and surgical wounds. Blood cultures that grow normal skin commensals will be included Endotracheal secretions that culture organisms other than normal upper respiratory tract flora Clostridium difficult related diarrhoea

Secondary Outcome Measures

  1. Incidence of central line associated blood stream infections [Until the end of the second calendar day following ICU discharge]

    CDC definition

  2. Incidence of catheter associated urinary tract infections [Until the end of the second calendar day following ICU discharge]

    CDC definition

  3. Incidence of ventilator associated pneumonia [Until the end of the second calendar day following ICU discharge]

    CDC definition

  4. Incidence of surgical site infection [Until the end of the second calendar day following ICU discharge]

    Public Health England definition

  5. Incidence of clostridium difficult diarrhoea [Until the end of the second calendar day following ICU discharge]

    Public Health England definition

  6. Incidence of acquisition of new methicilllin resistant staphylococcus aureus [Until the end of the second calendar day following ICU discharge]

  7. Incidence of secondary blood stream infections [Until the end of the second calendar day following ICU discharge]

    CDC definition

  8. Incidence of antibiotic resistance infections [Until the end of the second calendar day following ICU discharge]

    Pre-defined as Acinetobacter baumanii, Pseudomonas aeroginosa (Extended-Spectrum Beta Lacatamase [ESBL] producing), Klebsiella penumoniae (ESBL producing), Escherichia coli (ESBL producing), Stenotrophomonas maltophilia, Serratia marcescens, Clostridium difficile, or MRSA.

  9. Adverse event rate [24 weeks]

Other Outcome Measures

  1. Staff attitudes to electronic compliance monitoring [0 and 24 weeks]

    Quantitative and qualitative analysis of questionnaire data

  2. Surrogate measures of hand hygiene compliance [24 weeks]

    Alcohol hand rub usage, Soap usage and visual compliance monitoring

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients admitted to the intensive care units

  • All healthcare workers caring for the patients on the intensive care units.

Exclusion Criteria:
  • Healthcare workers with skin sensitivity to both alcohol hand rub and soap

Contacts and Locations

Locations

Site City State Country Postal Code
1 Royal Brompton and Harefield NHS Foundation Trust London United Kingdom

Sponsors and Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

Investigators

  • Principal Investigator: Patricia Cattini, MSc, Royal Brompton and Harefield NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Royal Brompton & Harefield NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT02511925
Other Study ID Numbers:
  • 2013IC004B
First Posted:
Jul 30, 2015
Last Update Posted:
Jul 30, 2015
Last Verified:
Jul 1, 2015
Keywords provided by Royal Brompton & Harefield NHS Foundation Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 30, 2015